Ignite Creation Date:
2025-12-25 @ 5:05 AM
Ignite Modification Date:
2026-03-13 @ 1:26 PM
Study NCT ID:
NCT00565227
Status:
TERMINATED
Last Update Posted:
2016-12-02
First Post:
2007-11-27
Is Gene Therapy:
True
Has Adverse Events:
False
Brief Title:
Phase I Study of Vorinostat in Combination With Docetaxel in Patients With Advanced and Relapsed Solid Malignancies.
Sponsor:
University of Michigan Rogel Cancer Center
Organization:
Key Dates - Follows AllAPIJSON File Order
Start Date:
2007-04
Start Date Type:
None
Primary Completion Date:
2008-11
Primary Completion Date Type:
ACTUAL
Completion Date:
2009-09
Completion Date Type:
ACTUAL
First Submit Date:
2007-11-27
First Submit QC Date:
None
Study First Post Date:
2007-11-29
Study First Post Date Type:
ESTIMATED
Results First Submit Date:
None
Results First Submit QC Date:
None
Results First Post Date:
None
Results First Post Date Type:
None
Results First Post QC Date:
None
Results First Post QC Date Type:
None
Disp First Submit Date:
None
Disp First Submit QC Date:
None
Disp First Post Date:
None
Disp First Post Date Type:
None
Last Update Submit Date:
2016-12-01
Last Update Post Date:
2016-12-02
Last Update Post Date Type:
ESTIMATED